Navigation Links
Questcor Proxy Proposals All Approved at 2011 Shareholder Meeting
Date:5/20/2011

ANAHEIM, Calif., May 20, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced the passage by its shareholders of the six proposals considered during the Company's annual meeting on May 19, 2011.

Shareholders voted in favor of the following:

  • All six nominees for the Board of Directors;
  • "Say-on-pay" advisory vote on executive officer compensation;
  • Advisory vote with respect to the frequency of future "say-on-pay" votes (once every year);
  • Amendment to the Company's 2006 Equity Incentive Award Plan, increasing the number of available shares of Questcor common stock by 3,500,000 shares;
  • Amendment to the Company's 2003 Employee Stock Purchase Plan, increasing the number of shares available for issuance by 600,000 shares; and
  • The retention of BDO USA, LLP as the Company's independent registered public accounting firm for the year ending December 31, 2011.

"On behalf of the board of directors, management and employees of Questcor, I would like to thank our shareholders for their support of the proposals considered at this year's annual meeting.  We believe that our shareholders' approval of the proposals to add shares to our Equity Incentive Award Plan and our Employee Stock Purchase Plan will play a key role in Questcor's ability to attract top talent to the organization and continue to generate strong returns for our shareholders," said Don M. Bailey, President and CEO of Questcor.

About Questcor

Questcor Pharmaceuticals, Inc. is a biopharmaceutical company whose primary product helps patients with serious, difficult-to-treat medical conditions.  Questcor's primary product is H.P. Acthar® Gel (repository corticotropin injection), an injectable drug that is approved by the FDA for the treatment of 19 indications
'/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Questcor Discusses ISS Proxy Recommendations; Provides Business Update
2. Questcor to Report First Quarter 2011 Earnings and Conduct Conference Call on April 26, 2011
3. Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011
4. Questcor Pharmaceuticals to Present at the Needham Healthcare Conference
5. Questcor Pharmaceuticals to Present at the Barclays Capital Global Healthcare Conference
6. Questcor Pharmaceuticals Selects BDO USA as its Auditor
7. Questcor Reports 2010 Financial Results
8. Questcor to Report Fourth Quarter and Full Year 2010 Earnings and Conduct Conference Call on February 23, 2011
9. Questcor Pharmaceuticals Reports Strong Finish to 2010
10. Questcor Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2011
11. Questcor Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/lnn7ss/investigation ) has ... on China,s Levothyroxine Market, 2010-2019" report to ... have the greatest effect of promoting growth on ... mainly promote the growth and development of bones, ... (GH) of pipuitary gland can,t work. Besides, pipuitary ...
(Date:9/3/2015)... 03, 2015 Research and ... the "Investigation Report on China,s Bromhexine Market, 2010-2019" ... pollution worsens, the incidence of respiratory disease keeps growing ... Bromhexine, a semisynthetic derivative of vasicine, is a mucolytic ... asthma associated with viscid or excessive mucus. It can ...
(Date:9/3/2015)... September 3, 2015 Pharma ... Lupin Pharmaceuticals, Inc. (Lupin) has launched its Duloxetine ... first and only generic Duloxetine formulation to become ... excited to bring this new strength to market, ... options for greater flexibility of treatment. ...
Breaking Medicine Technology:Investigation Report on China's Levothyroxine Market, 2010-2019 2China Bromhexine Market Report 2015-2019 2Lupin Launches First-ever Duloxetine 40mg Delayed-Release Capsules in the US 2Lupin Launches First-ever Duloxetine 40mg Delayed-Release Capsules in the US 3Lupin Launches First-ever Duloxetine 40mg Delayed-Release Capsules in the US 4
(Date:9/3/2015)... ... September 03, 2015 , ... DriButts, a non-profit organization ... Slingshot® Product Development Group to manufacture a long-lasting reusable diaper for warm weather ... plans to bring 600 DriButts Diapers to rural areas of Haiti during a ...
(Date:9/3/2015)... ... September 03, 2015 , ... Hope For ... for spring 2016. Scholarships are awarded two times each year to spouses or ... a national nonprofit dedicated to restoring a sense of self, restoring the family ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... announces the release of her debut book, “Stop Wasting Your Time Blaming Others ... Day (September 6), Hartley’s guide to overcoming life’s obstacles by taking full responsibility ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... disorder treatment for adults and adolescents struggling with anorexia, bulimia, binge eating ... the medical treatment team. As a Staff Psychiatrist, Dr. Calinoiu collaborates closely ...
(Date:9/3/2015)... ... September 03, 2015 , ... As ... increases for fully insured employer-sponsored health insurance plans, more employers are moving to ... to data released from the 2014 United Benefit Advisors (UBA) Health Plan Survey. ...
Breaking Medicine News(10 mins):Health News:DriButts Diapers Rely on Slingshot Help in Haiti 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 3Health News:Hope For The Warriors Spouse/Caregiver Scholarships Now Open for Spring 2016 2Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 2Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 3Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 2Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 3Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 2Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 3Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 4
... THURSDAY, June 9 (HealthDay News) -- Admissions for treatment ... between 1998 and 2008, while overall admissions for substance ... study released Thursday. , Benzodiazepines -- a class of ... -- include Valium, Halcion, Xanax, Ativan and Librium. Abuse ...
... possible to reprogram mature cells from human skin directly into ... unexpectedly simple technique involves activating three genes in the skin ... the formation of brain cells at the foetal stage. ... that stem cell research has faced. For the ...
... Sheffield,s School of Health and Related Research (ScHARR) has developed ... been accepted for use by the Department of Health. ... Jacques and James Fotheringham, were commissioned in January 2011 by ... index to look at deaths following a hospital admission. In ...
... to try to reduce racial and ethnic disparities in the ... the problem at any of the state,s 66 acute-care hospitals, ... effectiveness of the state,s novel approach. While the study, ... (June 9, 2011), found that racial and ethnic inequities for ...
... News) -- New findings on the link between migraine headaches ... an important role in the connection. As individual ... women. However, the new study found that men with migraines ... also have PTSD. In addition, the investigators found that ...
... HealthDay Reporter , WEDNESDAY, June 8 (HealthDay News) -- Girls ... explain some cases of autism in families with no history ... a certain number of duplications or deletions of one or ... explained Dr. Christian Schaaf, an assistant professor in the department ...
Cached Medicine News:Health News:Treatment for Abuse of Anti-Anxiety Drugs Tripled Over 10 Years 2Health News:New genetic technique converts skin cells into brain cells 2Health News:New hospital mortality rate index to be used across UK 2Health News:New hospital mortality rate index to be used across UK 3Health News:Pioneering hospital pay-for-performance program falls short of its goals 2Health News:Migraine Plus PTSD 4 Times More Likely in Men: Study 2Health News:Girls May Be More Resistant to Autism Than Boys: Study 2Health News:Girls May Be More Resistant to Autism Than Boys: Study 3Health News:Girls May Be More Resistant to Autism Than Boys: Study 4
...
Malis Curette, bayonet, titanium handle, stainless steel shaft, working distance 102 mm, length 203 mm....
Sundt Slim-Line Temporary Vessel Clips used for temporary vascular occlusion during intracranial surgical procedures. Non-magnetic, MP35N, MRI compatible, gold color. Bayonet....
Malis Needle Holders, bayonet, titanium. Working distance 2 1/2" (63 mm). Straight tip with width 0.6 mm....
Medicine Products: